Bioplex 2200 Apls Igm
System, Test, Anticardiolipin Immunological. 510(k) K130528, from Bio-Rad Laboratories (Benicia, CA). Product code MID, class 2.
As of Nov 17, 2026, K130528 is an FDA 510(k) held by Bio-Rad Laboratories, substantially equivalent on Oct 21, 2013 after 234 days, with 1 recall tied to it in FDA's recall database.
- Substantially equivalent: Oct 21, 2013
- Review time: 234 days
- Recalls: 1
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe BioPlex® 2200 Antiphospholipid Syndrome (APLS) IgM kit is a multiplex flow immunoassay intended for the semi-quantitative detection of IgM antibodies to Cardiolipin (CL.) and Beta-2 Glycoprotein I (β2GPI) in human serum and plasma (lithium heparin, sodium heparin, and sodium citrate).
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Hemosil Acustar Cardiolipin Igg, Igm And Igg And Igm ControlsK092181 · Instrumentation Laboratory CO · Mar 11, 2010
- Hemosil Acustar ANTI-B2 Glycoprotein-I; Igg, Igm, Igg Controls, Igm ControlsK091556 · Instrumentation Laboratory CO · May 21, 2010
Recalls
Recalls FDA ties to K130528, newest first; each opens FDA's recall record| Started | Reason | Status |
|---|---|---|
| Feb 28, 2023 | Z-1572-2023APLS IgM reagent kits were packaged with the incorrect conjugate, which could lead to an increase in false-positive and false-negative results. | Open, Classified |
Other MID Clearances
The newest 510(k)s for the same product code; see every MID device- Aptiva APS IgG Reagent; Aptiva APS IgM ReagentK223093 · Inova Diagnostics, Inc. · Dec 17, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 1, 2013
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files